Back to Journals » Biologics: Targets and Therapy » Volume 8 » default

Biologics: Targets and Therapy


Archived Journals

Archive: Volume 8, 2014

Multikinase inhibitors use in differentiated thyroid carcinoma

Jasim S, Ozsari L, Habra MA

Biologics: Targets and Therapy 2014, 8:281-291

Published Date: 4 December 2014

Inactivation of chromatin remodeling factors sensitizes cells to selective cytotoxic stress

Freeman MD, Mazu T, Miles JS, Darling-Reed S, Flores-Rozas H

Biologics: Targets and Therapy 2014, 8:269-280

Published Date: 14 November 2014

Targeted alpha anticancer therapies: update and future prospects

Allen BJ, Huang CY, Clarke RA

Biologics: Targets and Therapy 2014, 8:255-267

Published Date: 10 November 2014

Resistant mutations in CML and Ph+ALL – role of ponatinib

Miller GD, Bruno BJ, Lim CS

Biologics: Targets and Therapy 2014, 8:243-254

Published Date: 20 October 2014

Botulinum toxin type A products are not interchangeable: a review of the evidence

Brin MF, James C, Maltman J

Biologics: Targets and Therapy 2014, 8:227-241

Published Date: 6 October 2014

New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis

Frati F, Cecchi L, Scala E, Ridolo E, Dell'Albani I, Makrì E, Pajno G, Incorvaia C

Biologics: Targets and Therapy 2014, 8:221-226

Published Date: 12 September 2014

Golimumab in unresponsive ulcerative colitis

Lippert E, Müller M, Ott C

Biologics: Targets and Therapy 2014, 8:207-210

Published Date: 27 May 2014

Plasma membrane coenzyme Q: evidence for a role in autism

Crane FL, Löw H, Sun I, Navas P, Gvozdjáková A

Biologics: Targets and Therapy 2014, 8:199-205

Published Date: 29 May 2014

Anti-TNF therapy in Jordan: a focus on severe infections and tuberculosis

Alawneh KM, Ayesh MH, Khassawneh BY, Saadeh SS, Smadi M, Bashaireh K

Biologics: Targets and Therapy 2014, 8:193-198

Published Date: 22 April 2014

Clinical and comparative utility of afatinib in non-small cell lung cancer

D'Arcangelo M, Hirsch FR

Biologics: Targets and Therapy 2014, 8:183-192

Published Date: 23 April 2014

Long term efficacy and safety of etanercept in the treatment of psoriasis and psoriatic arthritis

Kivelevitch D, Mansouri B, Menter A

Biologics: Targets and Therapy 2014, 8:169-182

Published Date: 17 April 2014

Biologics: the role of delivery systems in improved therapy

Škalko-Basnet N

Biologics: Targets and Therapy 2014, 8:107-114

Published Date: 19 March 2014

Targeted therapy for sarcomas

Forscher C, Mita M, Figlin R

Biologics: Targets and Therapy 2014, 8:91-105

Published Date: 17 March 2014

Porcine dermis implants in soft-tissue reconstruction: current status

Smart NJ, Bryan N, Hunt JA, Daniels IR

Biologics: Targets and Therapy 2014, 8:83-90

Published Date: 10 March 2014

Does the cis/trans configuration of peptide bonds in bioactive tripeptides play a role in ACE-1 enzyme inhibition?

Siltari A, Viitanen R, Kukkurainen S, Vapaatalo H, Valjakka J

Biologics: Targets and Therapy 2014, 8:59-65

Published Date: 11 February 2014

Biologic targeting in the treatment of inflammatory bowel diseases [Retraction]

Bosani M, Ardizzone S, Porro GB

Biologics: Targets and Therapy 2014, 8:39-40

Published Date: 31 January 2014

Therapeutic vaccines and cancer: focus on DPX-0907

Karkada M, Berinstein NL, Mansour M

Biologics: Targets and Therapy 2014, 8:27-38

Published Date: 10 February 2014

Ziv-aflibercept in metastatic colorectal cancer

Patel A, Sun W

Biologics: Targets and Therapy 2014, 8:13-25

Published Date: 16 December 2013